In addition, the combination of PAK and PARP-targeting agents, did not merely produce cytostasis, but also resulted in cell death; increasing the frequency of apoptosis in PAK1 overexpressing and PAK1-amplified breast cancer cells by nearly a factor of 3 (Figure 5D). Here, PARP1 is linked to breast cancer.